Activity of curcumin against human cytomegalovirus infection in vitro.
10.7507/1001-5515.202108035
- Author:
Xiang DING
1
;
Jirong YUE
1
;
Birong DONG
1
;
Leng SEAN X
2
Author Information
1. The Center of Gerontology and Geriatrics, West China Hospital of Sichuan University, Chengdu 610041, P. R. China.
2. Division of Geriatric Medicine and Gerontology and Center on Aging and Immune Remodeling trisodium phosphonoformate, Department of Medicine, Johns Hopkins University School of Medicine, Maryland 21224, USA.
- Publication Type:Journal Article
- Keywords:
Curcumin;
Human cytomegalovirus;
In vitro experiment
- MeSH:
Humans;
Curcumin/therapeutic use*;
Cytomegalovirus/genetics*;
Cytomegalovirus Infections/drug therapy*;
Plaque, Atherosclerotic
- From:
Journal of Biomedical Engineering
2022;39(6):1158-1164
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to investigate the effect of curcumin (Cur) against human cytomegalovirus (HCMV) in vitro. Human embryonic lung fibroblasts were cultured in vitro. The tetrazolium salt (MTS) method was used to detect the effects of Cur on cell viability. The cells were divided into control group, HCMV group, HCMV + (PFA) group and HCMV + Cur group in this study. The cytopathic effect (CPE) of each group was observed by plaque test, then the copy number of HCMV DNA in each group was detected by quantitative polymerase chain reaction (qPCR), and the expression of HCMV proteins in different sequence was detected by Western blot. The results showed that when the concentration of Cur was not higher than 15 μmol/L, there was no significant change in cell growth and viability in the Cur group compared with the control group (P>0.05). After the cells were infected by HCMV for 5 d, the cells began to show CPE, and the number of plaques increased with time. Pretreatment with Cur significantly reduced CPE in a dose-dependent manner. After the cells were infected by HCMV, the DNA copy number and protein expression gradually increased in a time-dependent manner. Pretreatment with Cur significantly inhibited HCMV DNA copies and downregulate HCMV protein expression levels in a concentration-dependent manner, and the difference was statistically significant (P<0.05). In conclusion, Cur may exert anti-HCMV activity by inhibiting the replication of HCMV DNA and down-regulating the expression levels of different sequence proteins of HCMV. This study provides a new experimental basis for the development of anti-HCMV infectious drugs.
